The global ECMO Devices market size is predicted to grow from US$ 257 million in 2025 to US$ 323 million in 2031; it is expected to grow at a CAGR of 3.8% from 2025 to 2031.
Extracorporeal Membrane Oxygenation (ECMO) Systems is a new treatment method aimed at heart and lung failure disease. ECMO transport is an effective method of transferring patients with severe ARDS. It has multiple causes, and the diagnosis should be investigated and treatment commenced during ECMO. Since ECMO is a complicated and high-risk therapy, adequate training in its performance and creation of a referring hospital network are essential.
Market Drivers:
Rising Incidence of Cardiopulmonary Disorders:
Increasing cases of respiratory and cardiac diseases, such as chronic obstructive pulmonary disease (COPD), heart failure, and acute respiratory distress syndrome (ARDS), drive demand for ECMO devices. These devices are essential for patients whose heart and lungs need support, especially during severe cases or surgeries.
Advancements in ECMO Technology:
Innovations like portable ECMO devices, improved oxygenators, and better control systems have enhanced the safety and effectiveness of ECMO therapy, expanding its applications and encouraging adoption in a broader range of healthcare settings.
Increasing Use in COVID-19 and Critical Care:
The COVID-19 pandemic highlighted the need for advanced respiratory support for patients with severe respiratory failure. ECMO became a critical intervention in some severe cases, increasing awareness and demand for these devices.
Growing Use in Pediatric and Neonatal Care:
ECMO devices are increasingly being used in neonatal and pediatric ICUs to support infants with congenital heart disease or respiratory failure, expanding the market across different age groups.
Rising Number of Specialized Healthcare Facilities:
The increase in specialized healthcare centers, especially in developed economies, has made ECMO therapy more accessible, as these devices are often only available in well-equipped, high-acuity centers.
Market Challenges:
High Cost of ECMO Therapy and Devices:
ECMO treatment and the devices themselves are expensive, making them less accessible, particularly in low-income regions or countries with limited healthcare budgets. This limits adoption to only the most severe cases and to hospitals that can afford the technology.
Requirement of Skilled Professionals:
ECMO procedures are complex and require specialized training for operation and monitoring. A shortage of trained ECMO technicians and specialists poses a significant challenge, as improper handling can lead to serious complications.
Risk of Complications:
ECMO therapy has associated risks, such as bleeding, infection, and clotting issues, which can deter its usage in certain patients or situations. These risks require close monitoring and increase the need for experienced healthcare staff.
Strict Regulatory Standards:
ECMO devices are subject to stringent regulations by authorities like the FDA, which requires extensive testing for safety and efficacy. These regulatory hurdles can delay product approvals and increase costs for manufacturers.
Limited Awareness and Accessibility in Developing Regions:
In emerging markets, awareness about ECMO technology and access to it are limited due to a lack of trained professionals and high treatment costs. This restricts the market potential in regions where the healthcare infrastructure is less developed.
Global players of ECMO Devices include Medtronic, Getinge (Maquet), LivaNova (Sorin), Terumo and Fresenius Medical Care. Medtronic is the largest player, with a share about 34%. North America is the largest market, with a share about 40%, followed by Europe and China. In terms of product, VV (Veno-Venous) ECMO is the largest segment, with a share over 70%. In terms of application, Adult is the largest market, with a share about 80%.
The 鈥淓CMO Devices Industry Forecast鈥� looks at past sales and reviews total world ECMO Devices sales in 2024, providing a comprehensive analysis by region and market sector of projected ECMO Devices sales for 2025 through 2031. With ECMO Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world ECMO Devices industry.
This Insight Report provides a comprehensive analysis of the global ECMO Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on ECMO Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global ECMO Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for ECMO Devices and breaks down the forecast by Type, by End Users, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global ECMO Devices.
This report presents a comprehensive overview, market shares, and growth opportunities of ECMO Devices market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
VA (Veno-Arterial) ECMO
VV (Veno-Venous) ECMO
Segmentation by End Users:
Adult
Neonatal
Pediatric
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Medtronic
Getinge (Maquet)
LivaNova (Sorin)
Terumo
Fresenius Medical Care
Chinabridge(Shenzhen) Medical
Key Questions Addressed in this Report
What is the 10-year outlook for the global ECMO Devices market?
What factors are driving ECMO Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do ECMO Devices market opportunities vary by end market size?
How does ECMO Devices break out by Type, by End Users?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global ECMO Devices Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for ECMO Devices by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for ECMO Devices by Country/Region, 2020, 2024 & 2031
2.2 ECMO Devices Segment by Type
2.2.1 VA (Veno-Arterial) ECMO
2.2.2 VV (Veno-Venous) ECMO
2.3 ECMO Devices Sales by Type
2.3.1 Global ECMO Devices Sales Market Share by Type (2020-2025)
2.3.2 Global ECMO Devices Revenue and Market Share by Type (2020-2025)
2.3.3 Global ECMO Devices Sale Price by Type (2020-2025)
2.4 ECMO Devices Segment by End Users
2.4.1 Adult
2.4.2 Neonatal
2.4.3 Pediatric
2.5 ECMO Devices Sales by End Users
2.5.1 Global ECMO Devices Sale Market Share by End Users (2020-2025)
2.5.2 Global ECMO Devices Revenue and Market Share by End Users (2020-2025)
2.5.3 Global ECMO Devices Sale Price by End Users (2020-2025)
3 Global by Company
3.1 Global ECMO Devices Breakdown Data by Company
3.1.1 Global ECMO Devices Annual Sales by Company (2020-2025)
3.1.2 Global ECMO Devices Sales Market Share by Company (2020-2025)
3.2 Global ECMO Devices Annual Revenue by Company (2020-2025)
3.2.1 Global ECMO Devices Revenue by Company (2020-2025)
3.2.2 Global ECMO Devices Revenue Market Share by Company (2020-2025)
3.3 Global ECMO Devices Sale Price by Company
3.4 Key Manufacturers ECMO Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers ECMO Devices Product Location Distribution
3.4.2 Players ECMO Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for ECMO Devices by Geographic Region
4.1 World Historic ECMO Devices Market Size by Geographic Region (2020-2025)
4.1.1 Global ECMO Devices Annual Sales by Geographic Region (2020-2025)
4.1.2 Global ECMO Devices Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic ECMO Devices Market Size by Country/Region (2020-2025)
4.2.1 Global ECMO Devices Annual Sales by Country/Region (2020-2025)
4.2.2 Global ECMO Devices Annual Revenue by Country/Region (2020-2025)
4.3 Americas ECMO Devices Sales Growth
4.4 APAC ECMO Devices Sales Growth
4.5 Europe ECMO Devices Sales Growth
4.6 Middle East & Africa ECMO Devices Sales Growth
5 Americas
5.1 Americas ECMO Devices Sales by Country
5.1.1 Americas ECMO Devices Sales by Country (2020-2025)
5.1.2 Americas ECMO Devices Revenue by Country (2020-2025)
5.2 Americas ECMO Devices Sales by Type (2020-2025)
5.3 Americas ECMO Devices Sales by End Users (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC ECMO Devices Sales by Region
6.1.1 APAC ECMO Devices Sales by Region (2020-2025)
6.1.2 APAC ECMO Devices Revenue by Region (2020-2025)
6.2 APAC ECMO Devices Sales by Type (2020-2025)
6.3 APAC ECMO Devices Sales by End Users (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe ECMO Devices by Country
7.1.1 Europe ECMO Devices Sales by Country (2020-2025)
7.1.2 Europe ECMO Devices Revenue by Country (2020-2025)
7.2 Europe ECMO Devices Sales by Type (2020-2025)
7.3 Europe ECMO Devices Sales by End Users (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa ECMO Devices by Country
8.1.1 Middle East & Africa ECMO Devices Sales by Country (2020-2025)
8.1.2 Middle East & Africa ECMO Devices Revenue by Country (2020-2025)
8.2 Middle East & Africa ECMO Devices Sales by Type (2020-2025)
8.3 Middle East & Africa ECMO Devices Sales by End Users (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of ECMO Devices
10.3 Manufacturing Process Analysis of ECMO Devices
10.4 Industry Chain Structure of ECMO Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 ECMO Devices Distributors
11.3 ECMO Devices Customer
12 World Forecast Review for ECMO Devices by Geographic Region
12.1 Global ECMO Devices Market Size Forecast by Region
12.1.1 Global ECMO Devices Forecast by Region (2026-2031)
12.1.2 Global ECMO Devices Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global ECMO Devices Forecast by Type (2026-2031)
12.7 Global ECMO Devices Forecast by End Users (2026-2031)
13 Key Players Analysis
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic ECMO Devices Product Portfolios and Specifications
13.1.3 Medtronic ECMO Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Getinge (Maquet)
13.2.1 Getinge (Maquet) Company Information
13.2.2 Getinge (Maquet) ECMO Devices Product Portfolios and Specifications
13.2.3 Getinge (Maquet) ECMO Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Getinge (Maquet) Main Business Overview
13.2.5 Getinge (Maquet) Latest Developments
13.3 LivaNova (Sorin)
13.3.1 LivaNova (Sorin) Company Information
13.3.2 LivaNova (Sorin) ECMO Devices Product Portfolios and Specifications
13.3.3 LivaNova (Sorin) ECMO Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 LivaNova (Sorin) Main Business Overview
13.3.5 LivaNova (Sorin) Latest Developments
13.4 Terumo
13.4.1 Terumo Company Information
13.4.2 Terumo ECMO Devices Product Portfolios and Specifications
13.4.3 Terumo ECMO Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Terumo Main Business Overview
13.4.5 Terumo Latest Developments
13.5 Fresenius Medical Care
13.5.1 Fresenius Medical Care Company Information
13.5.2 Fresenius Medical Care ECMO Devices Product Portfolios and Specifications
13.5.3 Fresenius Medical Care ECMO Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Fresenius Medical Care Main Business Overview
13.5.5 Fresenius Medical Care Latest Developments
13.6 Chinabridge(Shenzhen) Medical
13.6.1 Chinabridge(Shenzhen) Medical Company Information
13.6.2 Chinabridge(Shenzhen) Medical ECMO Devices Product Portfolios and Specifications
13.6.3 Chinabridge(Shenzhen) Medical ECMO Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Chinabridge(Shenzhen) Medical Main Business Overview
13.6.5 Chinabridge(Shenzhen) Medical Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
